ECO ANIMAL HEALTH GROUP PLC Logo

ECO ANIMAL HEALTH GROUP PLC

Develops and markets pharmaceuticals and biologicals for pig and poultry health.

EAH | IL

Overview

Corporate Details

ISIN(s):
GB0005056469 (+2 more)
LEI:
2138009XN9DJ3YP7OB55
Country:
United Kingdom
Address:
THE GRANGE, 100 HIGH STREET, N14 6BN LONDON

Description

ECO Animal Health Group is a global company specializing in the development, registration, and marketing of pharmaceutical and biological products for animal health. The company's primary focus is on improving the health, welfare, and productivity of pigs and poultry by addressing economically significant respiratory and enteric diseases. Its key product is Aivlosin®, a macrolide antibiotic also marketed as Valosin®. Through its dedicated research and development, the company creates innovative solutions, including vaccines and other pharmaceuticals, to support sustainable and safe food production. ECO Animal Health operates worldwide, leveraging a global network of distributors and direct market presence.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-09 19:10
Holding(s) in Company
English 43.1 KB
2025-12-04 15:20
Director/PDMR Shareholding
English 23.7 KB
2025-12-01 08:25
Results for the six months ended 30 September 2025
English 379.7 KB
2025-11-20 11:00
Replacement: Notice of Results
English 15.1 KB
2025-11-20 08:25
Notice of Results
English 14.9 KB
2025-11-10 08:25
EMA Positive Opinion Received for ECOVAXXIN® MS
English 16.2 KB
2025-10-01 08:00
Head of Global R&D
English 12.1 KB
2025-08-21 13:29
Result of General Meeting
English 12.4 KB
2025-08-13 08:00
Block Listing Return
English 17.8 KB
2025-08-06 18:09
Holding(s) in Company
English 25.3 KB
2025-07-17 08:00
Holding(s) in Company
English 40.5 KB
2025-07-15 14:00
Director/PDMR Shareholding
English 22.8 KB
2025-07-14 08:00
Results for the year ended 31 March 2025
English 1.2 MB
2025-07-08 17:10
Notice of General Meeting and Notice of Results
English 15.3 KB
2025-03-13 08:00
R&D Day
English 11.7 KB

Automate Your Workflow. Get a real-time feed of all ECO ANIMAL HEALTH GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ECO ANIMAL HEALTH GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ECO ANIMAL HEALTH GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biopharmaceutical firm developing cannabinoid-based medicines for inflammatory conditions.
United Kingdom
ANAN
Designs, develops, and manufactures molecular diagnostic solutions and instruments.
Türkiye
ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Clinical-stage biopharmaceutical company developing therapeutics for CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and provides in-vitro diagnostic (IVD) solutions and instruments.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for acute cannabinoid intoxication.
United States of America
ANEB
AnGes, Inc. Logo
Biopharmaceutical firm developing gene-based and nucleotide-based medicines.
Japan
4563
Anika Therapeutics, Inc. Logo
A global joint preservation company developing solutions for orthopedic care.
United States of America
ANIK
ANIMALCARE GROUP PLC Logo
Develops and commercializes veterinary pharmaceutical products and services globally.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded, generic, and OTC pharmaceutical products.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Clinical-stage biotech developing a cell-protecting biologic for RVO and oncology.
Sweden
ANNX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.